News | Molecular Imaging | June 09, 2017

Siemens Healthineers Announces FDA Clearance of New Version of Molecular Imaging Software

Latest release of syngo.via VB20 for Molecular Imaging simplifies workflows and enhances ease-of-use for PET and SPECT

advanced visualization

The Food and Drug Administration (FDA) has cleared syngo.via VB20 for Molecular Imaging (MI) from Siemens Healthineers — a new release of the company’s established intelligent visualization software for multi-modality imaging. This latest version of syngo.via VB20 for MI contains dynamic new features and improvements designed to simplify workflows and enhance ease-of-use in positron emission tomography (PET) and single-photon emission computed tomography (SPECT). With software such as syngo.via VB20 for MI and a new name that underlines the company’s pioneering spirit and engineering expertise, Siemens Healthineers — the separately managed healthcare business of Siemens AG — helps healthcare providers worldwide meet current challenges and excel in their respective environments.

The software’s Multi-Foci Segmentation (MFS) feature for PET and SPECT permits automatic, one-click calculation of a patient’s whole-body tumor burden. Some clinicians leverage this calculation to assess patient response to therapy through reproducible quantification of the total tumor. Historically, this calculation has been performed manually and can be time-consuming.

The improved MI OncoBoard feature of syngo.via VB20 for MI displays pre-therapy and post-therapy treatment responses simultaneously, potentially enhancing understanding of disease progression and informing discussion during offline tumor board meetings.

The improved MI Neurology feature of syngo.via VB20 for MI has two new capabilities. Users can now compare data from two different time points — similar to the new MI OncoBoard feature — to gauge disease progression. Also, clinicians can not only visualize and quantify patient uptake of certain amyloid radiopharmaceutical, but they also can compare the scanned patient with a database of normal patients to provide value to quantification numbers.

For more information: www.usa.siemens.com/healthcare

Related Content

Developed by medical AI company Lunit, Software detects breast cancer with 97% accuracy; Study in Lancet Digital Health shows that Lunit INSIGHT MMG-aided radiologists showed an increase in sensitivity

Lunit INSIGHT MMG

News | Artificial Intelligence | June 02, 2020
June 2, 2020 — Lunit announced that its artificia...
Nuclear Cardiology Optimistic About Return to Pre-COVID-19 Exam Levels. An American Society of Nuclear Cardiology (ASNC) member survey are confident nuclear cardiology volumes will return to pre-pandemic levels. #COVID19 #SARScov2
News | Nuclear Imaging | June 01, 2020
June 1, 2020 — While acknowledging the challenges their specialty is facing, more than two-thirds of respondents to a
AIR Recon DL delivers shorter scans and better image quality (Photo: Business Wire)

AIR Recon DL delivers shorter scans and better image quality (Photo: Business Wire).

News | Artificial Intelligence | May 29, 2020
May 29, 2020 — GE Healthcare announced U.S.
Largest case series (n=30) to date yields high frequency (77%) of negative chest CT findings among pediatric patients (10 months-18 years) with COVID-19, while also suggesting common findings in subset of children with positive CT findings

A and B, Unenhanced chest CT scans show minimal GGOs (right lower and left upper lobes) (arrows) and no consolidation. Only two lobes were affected, and CT findings were assigned CT severity score of 2. Image courtesy of American Journal of Roentgenology (AJR)

News | Coronavirus (COVID-19) | May 29, 2020
May 29, 2020 — An investigation published open-access in the ...
The paradox is that COVID-19 has manifested the critical need for exactly what the rules require: advancement of interoperability and digital online access to clinical data and imaging, at scale, for care coordination and infection control.

The paradox is that COVID-19 has manifested the critical need for exactly what the rules require: advancement of interoperability and digital online access to clinical data and imaging, at scale, for care coordination and infection control. Getty Images

Feature | Coronavirus (COVID-19) | May 28, 2020 | By Matthew A. Michela
One year after being proposed, federal rules to advance interoperability in healthcare and create easier access for p
The opportunity to converge the silos of data into a cross-functional analysis can provide immense value during the COVID-19 outbreak and in the future

Getty Images

Feature | Coronavirus (COVID-19) | May 28, 2020 | By Jeff Vachon
In the midst of the coronavirus pandemic normal
United Imaging's uMR OMEGA is designed to provide greater access to magnetic resonance imaging (MRI) with the world’s first ultra-wide 75-cm bore 3T MRI.
News | Magnetic Resonance Imaging (MRI) | May 27, 2020
May 27, 2020 — United Imaging's...
In April, the U.S. Food and Drug Administration (FDA) cleared Intelerad’s InteleConnect EV solution for diagnostic image review on a range of mobile devices.
Feature | PACS | May 27, 2020 | By Melinda Taschetta-Millane
Fast, easily accessible patient images are crucial in this day and age, as imaging and medical records take on a new
There were several new developments in digital radiography (DR) technology at the 2019 Radiological Society of North America (RSNA) annual meeting. These trends included integration of artificial intelligence (AI) auto detection technologies, more durable glassless detector plates, and technologies to pull more diagnostic data out of X-ray imaging. Some vendors also have redesigned their DR systems to make them more user-friendly and ergonomic. 
Feature | Digital Radiography (DR) | May 26, 2020 | By Dave Fornell
There were several new developments in digital rad...